Cargando…
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
SIMPLE SUMMARY: Prostate cancer is the second most common cancer in men world-wide, with nearly 1.3 million new cases each year, and over the next twenty years the incidence and death rate are predicted to nearly double. For decades, this lethal disease has been more or less successfully treated usi...
Autores principales: | Estébanez-Perpiñá, Eva, Bevan, Charlotte L., McEwan, Iain J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865914/ https://www.ncbi.nlm.nih.gov/pubmed/33572755 http://dx.doi.org/10.3390/cancers13030509 |
Ejemplares similares
-
Topological dynamics of an intrinsically disordered N‐terminal domain of the human androgen receptor
por: Sheikhhassani, Vahid, et al.
Publicado: (2022) -
A sting in the tail: the N-terminal domain of the androgen receptor as a drug target
por: Monaghan, Amy E, et al.
Publicado: (2016) -
How Goes the Fight?
Publicado: (1921) -
Trinucleotide repeats and protein folding and disease: the perspective from studies with the androgen receptor
por: Orafidiya, Folake A, et al.
Publicado: (2015) -
The Impact of Point Mutations in the Human Androgen Receptor: Classification of Mutations on the Basis of Transcriptional Activity
por: Hay, Colin W., et al.
Publicado: (2012)